Honorary Chairman

1

Sang Guowei

Vice Chairman of the Standing Committee of 11th National People’s Congress, Academician of Chinese Academy of Engineering (CAE), Chief Engineer of National Science and Technology Major Project for Major New Drug Research and Development

Chairman

2

Chen Kaixian

Academician of Chinese Academy of Sciences (CAS), Researcher, Director of Academic Degree Committee of Shanghai Institute of Materia Medica (SIMM), CAS; Director of Academic Committee of Shanghai University of Traditional Chinese Medicine

Deputy Chairman

3

Jiang Jiandong

Director of Institute of Materia Medica (IMM), Chinese Academy of Medical Sciences (CAMS)

4

Zhang Boli

Academician of CAE, Former President of China Academy of Chinese Medical Sciences, President of Tianjin University of Traditional Chinese Medicine

5

Jiang Hualiang

Academician of CAS, Researcher of SIMM, CAS

Member

6

Zhao Kai

Academician of CAE, Researcher of National Vaccine and Serum Institute

7

Chen Zhaolong

Academician of CAE, Honorary Dean of Kaohsiung Chang Gung Memorial Hospital

8

Ding Jian

Academician of CAE, Academician of the World Academy of Sciences, Dean of School of Pharmacy of University of Chinese Academy of Sciences, Director of Academic Committee of SIMM, CAS

9

Wang Guangji

Academician of CAE, Chairman of the Academic Committee & Director of Key Laboratory,China Pharmaceutical University,

10

Ge Junbo

Academician of CAS, Dean of Institutes of Biomedical Sciences, Fudan University, Director of Cardiology Department of Zhongshan Hospital, Fudan University

11

Wei Yuquan

Academician of CAS, Professor of National Key Laboratory of Biotherapy, Sichuan University

12

Li Lin

Academician of CAS, President of Shanghai Institutes for Biological Sciences, CAS 

13

Chen Jianfeng

Academician of CAE, Vice President of Beijing University of Chemical Technology

14

Yue Jianmin

Academician of CAS, Researcher of SIMM, CAS

15

Li Zhaoshen

Academician of CAE, Director of Department of Gastroenterology of Changhai Hospital of Shanghai

16

Ye Yuru

Academician of CAS, Foreign Academician of National Academy of Sciences, United States, Vice President of Hong Kong University of Science and Technology

17

Wang Hongyang

Academician of CAE, Director of The National Center for Science in Hepatocellular Carcinoma, Director of International Cooperative Center for Biosignal Transduction Research, the Second Military Medical University

18

Yu Jinming

Academician of CAE, Honorary President/Principal of Shandong First Medical University & Shandong Academy of Medical Sciences, President of Shandong Cancer Hospital

19

Ning Guang

Academician of CAE, Vice President of Ruijin Hospital, Shanghai Jiaotong University

20

Wang Junzhi

Academician of CAE, Chief Expert for Biological Product Testing in National Institutes for Food and Drug Control (NIFDC)

21

Lai Maode

President of China Pharmaceutical University

22

Wu Chunfu

Professor of Shenyang Pharmaceutical University

23

Wu Xiaoming

Professor & Former President of China Pharmaceutical University

24

Chen Xiaoguang

Director of Department of Pharmacology of IMM, CAMS

25

Ji Jiafu

President of Beijing Cancer Hospital

26

Wang Yongjun

Executive Deputy Dean of Beijing Tiantan Hospital, Capital Medical University

27

Shi Yuankai

Deputy Director of National Cancer Center, Vice President of Cancer Hospital, CAMS

28

Zhang Shuyang

Vice President and Party Secretary of Peking Union Medical College Hospital (PUMCH), Vice President of Peking Union Medical College (PUMC)

29

Wu Yilong

Tenured Professor & Director of Guangdong General Hospital (GGH)

30

Zhou Zhiguang

President of the Second Xiangya Hospital of Central South University, Director of National Clinical Research Center for Metabolic Diseases

31

Qin Shukui

Director of Cancer Center of General Hospital of Eastern Theater Command

32

Huo Yong

Director of Department of Cardiology and Heart Center, Peking University First Hospital

33

Ma Jun

Executive Vice President of Sun Yat-Sen University Cancer Center

34

He Ruyi

Chief Scientist at SDIC, Former Chief Scientist at Center for Drug Evaluation of NMPA

35

Hou Jian

Director of Department of Hematology of Renji Hospital of Shanghai Jiaotong University School of Medicine

36

Li Wenbin

Director of Department of Neuro-Oncology of Beijing Tiantan Hospital, Capital Medical University

37

Li Jia

Director of SIMM, CAS, Director of State Key Laboratory of Drug Research

38

Liang Jun

Vice President, Director of Cancer Center of Peking University International Hospital, Deputy Director of Comprehensive Internal Medicine Treatment Department of Beijing Cancer Hospital

39

Ma Jun

Director of Harbin Institute of Hematology

40

Hu Yi

Director of Oncology Department, Chinese PLA General Hospital

41

Wang Weiqing

Director of the Department of Endocrine and Metabolism of Ruijin Hospital, Shanghai Jiaotong University School of Medicine

42

Shi Jin

Director of Neurology Department of Air Force General Hospital, PLA

43

Zhang Shucai

Director of the Oncology Medicine Department of Beijing Chest Hospital, Capital Medical University

44

Dong Qiang

Director of Department of Neurology of Huashan Hospital, Fudan University, Deputy Director of Neurology Institute, Fudan University

45

Linghu Enqiang

Director of Department of Gastroenterology, Chinese PLA General Hospital

46

Li Jin

Director of Department of Oncology of Shanghai East Hospital, Tongji University

47

Zhong Wu

Director of National Engineering Research Center for the Emergency Drug, Academy of Military Medical Sciences

48

Zhu Xiaoxin

Researcher of Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences

49

Xuan Jianwei

Director of Medicine Economic Research Institute of School of Pharmaceutical Sciences, Sun Yat-Sen University

50

Shen Xinliang

Vice Chairman of the Committee of Genetic Engineering Drugs, Polypeptide Drugs and Vaccines of China Medicinal Biotech Association (CMBA), Former Chief Scientist of CNBG

51

Huang Jiaoti

Tenure Professor and Department Head of Duke University Medical Center

52

Song Wenru

Co-founder, President and Head of R&D of Kira Pharmaceuticals

53

Ren Jin

Director of Center for Drug Safety Evaluation and Research of SIMM, CAS

54

Wang Xinghe

Director of New Drug Clinical Trial Center of Beijing Shijitan Hospital, Capital Medical University

55

Cui Yimin

Director of Clinical Trial Center, Peking University First Hospital

56

Hu Xin

Director of Department of Pharmacy, Beijing Hospital

57

Wang Xiaoling

Director of Department of Pharmacy, Beijing Children's Hospital, Capital Medical University

58

Li Kexin

Director of Beijing Hospital Clinical Trial Research Center (BJH-CTC)

59

Song Ruilin

Chairman of China Pharmaceutical Innovation and Research Development Association (PhIRDA)